Kazia Therapeutics maintained at Buy as BTIG raises target
BTIG maintained Kazia Therapeutics at Buy and raised its price target to $40.00 per share from $34.00,
Ratings actions GMT) Kazia Therapeutics Price Target Raised to $40.00/Share From $34.00 by BTIGRatings actions